Agilent to Acquire BioTek, Strengthening Leadership Position in Growing Cell Analysis Segment
Agilent Technologies, Inc. (A)
Last agilent technologies, inc. earnings: 2/18 04:05 pm
Check Earnings Report
US:NYSE Investor Relations:
investor.agilent.com
Company Research
Source: Business Wire
Highlights: Combined portfolio enables Agilent to provide a more complete and integrated solution for customers in the important and fast-growing area of live cell analysisBioTek is a recognized leader for plate-readers and imaging systems with complementary offerings to Agilent’s portfolioExcellent growth potential; the acquisition positions Agilent well in the large and growing immuno-oncology and immunotherapy markets and expands the company’s presence in biopharma, academia and researchStrong profitability; expected to be immediately accretive to non-GAAP earnings and compounding growth thereafter SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced it has signed a definitive agreement to acquire privately-owned BioTek Instruments for $1.165 billion. With anticipated tax benefits for Agilent, the net purchase price is expected to be approximately $1.05 billion.This press release features multimedia. View the full release here: https://www.bu
Show less
Read more
Impact Snapshot
Event Time:
A
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
A alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
A alerts
High impacting Agilent Technologies, Inc. news events
Weekly update
A roundup of the hottest topics
A
News
- Agilent to Present at the 43rd Annual J.P. Morgan Healthcare ConferenceBusiness Wire
- Agilent Technologies, Inc. (NYSE: A) had its price target raised by analysts at Citigroup Inc. to $165.00. They now have a "buy" rating on the stock.MarketBeat
- Genomics in Cancer Care: North American Market Growth Forecasts and Business Opportunities, 2024-2031 [Yahoo! Finance]Yahoo! Finance
- Preimplantation Genetic Testing Market to hit USD 1.7 billion by 2032, says Global Market Insights Inc. [Yahoo! Finance]Yahoo! Finance
- Agilent Technologies, Inc. (NYSE: A) had its price target lowered by analysts at Bank of America Co. from $153.00 to $150.00. They now have a "neutral" rating on the stock.MarketBeat
A
Earnings
- 11/25/24 - Beat
A
Sec Filings
- 12/20/24 - Form 10-K
- 12/13/24 - Form 8-K
- 12/3/24 - Form 4
- A's page on the SEC website